English
This article is from International Journal of Critical Illness and Injury Science , volume 3 . Abstract Aim:: To evaluate the efficacy and safety of nimesulide 1% w/w spray in minor soft-tissue injuries in adult Indians through a multicentric, open-labeled, phase III trial. Materials and Methods:: 125 eligible patients, who met the selection criteria and gave written informed consent, were screened, enrolled, and treated with nimesulide 1% spray for seven days. Patients were assessed at baseline, day 1, day 4, and day 8 for efficacy and safety. Primary efficacy variable pain intensity, was measured using a NRS 1-100 mm (numerical rating scale). Secondary efficacy variables were degree of inflammation and edema and degree of functional impairment; overall assessment of efficacy was done by patient (patient global assessment – PGA) and by investigator (investigator global assessment – IGA) on days 4 and 8. Result:: There was a statistically significant reduction in the NRS score, degree of pain, edema (inflammation), and improvement in functional impairment on days 4 and 8 and in serum creatine kinase levels on day 8 in comparison with baseline. Global assessment of efficacy on day 8
Sign in with your free account to read, download EPUBs or listen.
Ebook · A phase III trial evaluating the efficacy and tolerability of nimesulide 1% spray in patients with soft-tissue injuries. · Khan, Mazharuddin Ali, Rao, Madhusudhan, Reddy, Madan M., Tamloorker, Datta, Gumdal, Vishesh, Latha, Moodahadu S., Krishnankutty, Binny · Internet Archive